Published in Medical Device Business Week, December 17th, 2008
"This paradox has not been solved yet. Recent studies have identified modifications of intracellular signaling proteins and target genes that could contribute to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.